|
MechanismMLLT1 modulators |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Bridge Medicines LLC
0 Patents (Medical) associated with Bridge Medicines LLC
100 Deals associated with Bridge Medicines LLC
100 Translational Medicine associated with Bridge Medicines LLC